FDA Inspection 1155915 — Novozymes (China) Biotechnology
The FDA completed an inspection of Novozymes (China) Biotechnology on Sep 29, 2021 in Tianjin. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 29, 2021
- Fiscal Year
- 2021
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Tianjin (China)